» Articles » PMID: 20409595

Challenges in Reducing the Burden of Otitis Media Disease: an ENT Perspective on Improving Management and Prospects for Prevention

Overview
Specialty Pediatrics
Date 2010 Apr 23
PMID 20409595
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Acute otitis media (AOM) is a major public health concern. This frequent disease of childhood is a leading cause of physician visits, a major component of paediatric healthcare burden, and a key contributor to antibiotic resistance. An international expert group comprising mainly ear, nose, and throat physicians met in June 2008 to discuss the optimal management of AOM, particularly with regards to unmet needs in diagnosis and management. Current guidelines do not help identify which patients are most at risk for severe or complicated AOM. Diagnosis of AOM is also complicated by a lack of correlation between clinical signs and symptoms and responsible pathogens. Consequently, treatment of AOM is not always appropriate, and the long-term overuse of antibiotics in AOM reduces the effectiveness of treatment and places children at risk for drug-resistant infections. There is a need for educational and research initiatives to improve diagnostic accuracy and management of AOM. Because there is currently no ideal treatment, vaccination is an attractive additional approach for managing AOM and reducing its burden.

Citing Articles

Role as a Probiotic in Children's Health and Disease Prophylaxis-A Systematic Review.

Al-Akel F, Chiperi L, Eszter V, Bacarea A Life (Basel). 2025; 14(12.

PMID: 39768321 PMC: 11676405. DOI: 10.3390/life14121613.


Acute otitis media in children 6 months to 2 years of age.

Goldman R Can Fam Physician. 2022; 68(8):589-590.

PMID: 35961722 PMC: 9374071. DOI: 10.46747/cfp.6808589.


INFLATE: a protocol for a randomised controlled trial comparing nasal balloon autoinflation to no nasal balloon autoinflation for otitis media with effusion in Aboriginal and Torres Strait Islander children.

Walsh R, Reath J, Gunasekera H, Leach A, Kong K, Askew D Trials. 2022; 23(1):309.

PMID: 35421984 PMC: 9009496. DOI: 10.1186/s13063-022-06145-8.


Discovery of Small-Molecule VapC1 Nuclease Inhibitors by Virtual Screening and Scaffold Hopping from an Atomic Structure Revealing Protein-Protein Interactions with a Native VapB1 Inhibitor.

Sun H, Coussens N, Danchik C, Wachsmuth L, Henderson M, Patnaik S J Chem Inf Model. 2022; 62(5):1249-1258.

PMID: 35103473 PMC: 10041999. DOI: 10.1021/acs.jcim.1c01188.


Impaired mucociliary motility enhances antigen-specific nasal IgA immune responses to a cholera toxin-based nasal vaccine.

Lan H, Suzuki H, Nagatake T, Hosomi K, Ikegami K, Setou M Int Immunol. 2020; 32(8):559-568.

PMID: 32347929 PMC: 9262165. DOI: 10.1093/intimm/dxaa029.